Cancer immunotherapy
Types of monoclonal antibodies
Columns: Antibody | Brand name | Approval date | Type | Target
Alemtuzumab | Campath | 2001 | humanized | CD52 | Bevacizumab | Avastin | 2004 | humanized | vascular endothelial growth factor | Brentuximab vedotin | Adcetris | 2011 | chimeric | CD30 | Cetuximab | Erbitux | 2004 | chimeric | epidermal growth factor receptor | Gemtuzumab ozogamicin | Mylotarg | 2000 | humanized | CD33 | Ibritumomab tiuxetan | Zevalin | 2002 | murine | CD20 | Panitumumab | Vectibix | 2006 | human | epidermal growth factor receptor | Rituximab | Rituxan, Mabthera | 1997 | chimeric | CD20 | Trastuzumab | Herceptin | 1998 | humanized | ErbB2